Whitepaper – T-cell engagers: From drug discovery hurdles to next-gen solutions
Read this new Whitepaper from WuXi Biologics.
- Innovative platforms across key stages of TCE drug discovery, with real-world case studies on high-purity production and fit-for-purpose in vitro & in vivo studies.
- Proven approaches to navigate key development challenges, such as structural complexity, CRS risks, and tumour heterogeneity.
- Forward-looking strategies combining TCEs with immunomodulatory domains or checkpoint inhibitors.
